Latest market price
1.03
-0.11-9.65%
OverviewShort InterestFilings
VRXAVeraxa Biotech Holding AG·NASDAQ
1.03-9.65%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 29, 20264Statement of changes in beneficial ownership
Oct 21, 20264Statement of changes in beneficial ownership
Oct 15, 20266-KForeign issuer report
Sep 14, 20263Initial statement of beneficial ownership
Sep 04, 2026424B3Prospectus
Sep 04, 2026424B3Prospectus
Sep 04, 20266-KForeign issuer report
Aug 31, 20264Statement of changes in beneficial ownership
Aug 31, 20264Statement of changes in beneficial ownership
Aug 24, 20266-KForeign issuer report
Aug 20, 20263Initial statement of beneficial ownership
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 10, 2026424B5Prospectus
Aug 10, 2026424B5Prospectus
Aug 06, 2026EFFECTNotice of effectiveness
Aug 06, 2026EFFECTNotice of effectiveness
Aug 05, 2026F-1/AF-1/A
Aug 05, 2026F-1/AF-1/A
Jul 31, 2026F-1F-1
Jul 31, 20266-KForeign issuer report
Jul 31, 2026F-1F-1
Jul 27, 20266-KForeign issuer report
Jul 27, 20266-KForeign issuer report
Jun 18, 20266-KForeign issuer report
Jun 16, 2026SC 13DBeneficial ownership statement (active)
#1 / 25 of 56
Page
▼
/ 3